OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.

Last updated: March 20, 2026
Sponsor: Centre Hospitalier Universitaire de Nice
Overall Status: Completed

Phase

N/A

Condition

Brain Tumor

Eye Disorders/infections

Pituitary Disorders

Treatment

Neurosurgery

Clinical Study ID

NCT04074642
19-AOI-06
  • Ages > 18
  • All Genders

Study Summary

The aim of the study is to assess accurancy of OCT angiography as a pronostic marker for patients undergoing neurosurgery for compressiver macroadenoma as compared with visual acuity, visual field and OCT.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • pituitary compressive adenoma (for experimental group)

  • pituitary non compressive adenoma

Exclusion

Exclusion Criteria:

  • retinian disease

  • amblyopia

  • parkinson disease

  • pregnant woman

Study Design

Total Participants: 21
Treatment Group(s): 1
Primary Treatment: Neurosurgery
Phase:
Study Start date:
November 14, 2019
Estimated Completion Date:
February 22, 2023

Connect with a study center

  • CHU de NICE

    Nice, 06000
    France

    Site Not Available

  • Hôpital Pasteur 2 - Service d'Ophtalmologie

    Nice, 06001
    France

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.